March 21, 2014 – (This post relayed from the FDA Press Release site. No editing; if any, copyrights remain with FDA or its respective holder(s)). The U.S. Food and Drug Administration today approved Otezla (apremilast) to treat adults with active …

FDA approves Apremilast [Otezla] to treat psoriatic arthritis (PsA) Read more »